Four buyouts (and one rumor that didn’t materialize); Isomorphic Labs’ first pharma deals; A CAR-T IPO; #JPM24 highlights; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.

From what…
Click here to view original post